NDRG1 and breast cancer: In our current study, the MSP results demonstrated that the status of methylation had a greater frequency in 87 breast tumors compared with corresponding normal tissues (P < 0.001), which showed that NDRG1 promoter methylation status was relative to the genetic risk variants for breast cancer.